140 Job Losses After R-PR/Fisons Integration
Following the acquisition of Fisons by Franco-American company Rhone-Poulenc Rorer last October, the UK business operations of both will be combined with effect from April. The new integrated company will be based initially at R-PR's offices in Eastbourne.
In due course, and hopefully by December 1996, a new location for the company will be found. But unfortunately, says Tim Allington, managing director of R-PR for the UK and Ireland, the reorganization and relocation will involve some redundancies; a figure of around 140 sales and marketing positions out of a total 470 employed by the separate companies has been mentioned. These redundancies will occur at both the Eastbourne site and at Fisons' Coleorton, Leicestershire facility.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze